prodrugs. To elaborate these NO prodrugs various water-soluble ligands were used such as P(CH2OH)3, 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (PTA), 1,2-bis[bis(hydroxymethyl)phosphino]ethane (HMPE), 1,2-bis[bis(hydroxymethyl)phosphino]benzene (TMBz), cysteamine, cysteamine hydrochloride, L-cysteine ethyl ester hydrochloride (LCEE) and pyrimidine-2-thiol (pyrim). The mononuclear complexes Fe(NO)2P(CH2OH)3Cl
已开发出一类新型的
水溶性亚硝基
铁络合物用作NO供体 前药。详细说明这些前药 各种
水溶性
配体使用例如P(CH 2 OH)3,1,3,5-三氮杂-7-
磷杂
三环[3.3.1.1]
癸烷(
PTA),1,2-双[双(羟甲基)膦基]
乙烷 (HMPE), 1,2-双[双(羟甲基)膦基]苯 (
TMBz), 半
胱胺,
盐酸半
胱胺,
L-半胱氨酸乙酯盐酸盐 (LCEE)和
嘧啶-2-
硫醇(pyrim)。单核络合物Fe(NO)2 P(CH 2 OH)3 Cl 1,Fe(NO)2(P(CH 2 OH)3)2 2,Fe(NO)2(
PTA)2 3,Fe(NO)2 HMPE 4,Fe(NO)2
TMBz 5,[Fe(NO)2 pyrimI] 10,[Fe(NO)3 P(CH 2 OH)3 ] [X](X = PF 6,SbF 6,BF 4)11-13和双核物质[Fe(NO)2 S(CH 2)2 NH 3 Cl] 2 6a,[Fe(NO)2